Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA (Cytosine-5-)-Methyltransferases | 10 | 2018 | 304 | 1.740 |
Why?
|
| Hematopoietic Stem Cells | 13 | 2020 | 1236 | 1.490 |
Why?
|
| DNA Methylation | 15 | 2022 | 2671 | 1.420 |
Why?
|
| Hematopoiesis | 3 | 2018 | 562 | 0.730 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 336 | 0.500 |
Why?
|
| Gene Deletion | 1 | 2018 | 1440 | 0.440 |
Why?
|
| Epigenesis, Genetic | 8 | 2020 | 1397 | 0.430 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 1905 | 0.380 |
Why?
|
| CpG Islands | 5 | 2017 | 631 | 0.380 |
Why?
|
| Genome, Human | 3 | 2017 | 1868 | 0.350 |
Why?
|
| DNA Modification Methylases | 2 | 2022 | 173 | 0.340 |
Why?
|
| Leukemia | 2 | 2016 | 1633 | 0.330 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 2288 | 0.320 |
Why?
|
| 5-Methylcytosine | 3 | 2018 | 55 | 0.270 |
Why?
|
| Epigenomics | 3 | 2018 | 265 | 0.270 |
Why?
|
| Cell Lineage | 3 | 2018 | 663 | 0.270 |
Why?
|
| Gene Editing | 2 | 2017 | 217 | 0.250 |
Why?
|
| Histones | 4 | 2022 | 1462 | 0.240 |
Why?
|
| Cytosine | 2 | 2014 | 141 | 0.220 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2018 | 6932 | 0.220 |
Why?
|
| Bone Marrow Cells | 4 | 2016 | 939 | 0.220 |
Why?
|
| Cell Differentiation | 7 | 2020 | 4043 | 0.200 |
Why?
|
| Mice | 16 | 2022 | 34393 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 6927 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 2 | 2018 | 3076 | 0.170 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 75 | 0.160 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 48 | 0.160 |
Why?
|
| Animals | 18 | 2022 | 59489 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2018 | 2485 | 0.160 |
Why?
|
| Chromatin | 2 | 2020 | 950 | 0.150 |
Why?
|
| Clone Cells | 1 | 2018 | 547 | 0.150 |
Why?
|
| Sulfites | 1 | 2017 | 44 | 0.150 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2016 | 57 | 0.140 |
Why?
|
| Receptors, Erythropoietin | 1 | 2016 | 69 | 0.140 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2016 | 464 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2016 | 147 | 0.130 |
Why?
|
| Mutation Rate | 2 | 2013 | 222 | 0.120 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2014 | 83 | 0.120 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 271 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 4787 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 328 | 0.120 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2013 | 33 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 358 | 0.110 |
Why?
|
| Side-Population Cells | 1 | 2013 | 18 | 0.110 |
Why?
|
| Genomic Instability | 2 | 2013 | 517 | 0.110 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 623 | 0.110 |
Why?
|
| Conserved Sequence | 1 | 2013 | 469 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 1557 | 0.100 |
Why?
|
| Doxorubicin | 1 | 2018 | 3005 | 0.100 |
Why?
|
| Cisplatin | 1 | 2018 | 2432 | 0.100 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 802 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 610 | 0.090 |
Why?
|
| Disease | 1 | 2012 | 165 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2013 | 746 | 0.090 |
Why?
|
| Mutation | 4 | 2018 | 15167 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 4027 | 0.090 |
Why?
|
| Software | 1 | 2017 | 1326 | 0.090 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 601 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2018 | 1498 | 0.080 |
Why?
|
| CCCTC-Binding Factor | 2 | 2020 | 34 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2013 | 3022 | 0.080 |
Why?
|
| Multiple Myeloma | 1 | 2020 | 2152 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 834 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2362 | 0.070 |
Why?
|
| Base Sequence | 1 | 2013 | 4886 | 0.070 |
Why?
|
| Dioxygenases | 2 | 2018 | 160 | 0.070 |
Why?
|
| Lysine | 2 | 2020 | 419 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2334 | 0.070 |
Why?
|
| Cell Self Renewal | 2 | 2016 | 60 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1514 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2016 | 5672 | 0.060 |
Why?
|
| Neoplasms, Experimental | 2 | 2018 | 745 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2020 | 1139 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2018 | 7241 | 0.060 |
Why?
|
| Humans | 14 | 2020 | 262248 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2016 | 5598 | 0.050 |
Why?
|
| Short Stature Homeobox Protein | 1 | 2020 | 11 | 0.050 |
Why?
|
| Male | 5 | 2018 | 123338 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 836 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2020 | 123 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2020 | 248 | 0.040 |
Why?
|
| Tenericutes | 1 | 2017 | 2 | 0.040 |
Why?
|
| Microinjections | 1 | 2017 | 94 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2020 | 406 | 0.040 |
Why?
|
| Mycobacterium avium | 1 | 2016 | 22 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 566 | 0.040 |
Why?
|
| K562 Cells | 1 | 2017 | 339 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2012 | 2085 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 904 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2016 | 232 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 14288 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 277 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 278 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 591 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 2232 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 518 | 0.030 |
Why?
|
| Adenosine | 1 | 2016 | 291 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 1145 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1505 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 560 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 454 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 511 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 581 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 1148 | 0.030 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2012 | 83 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2014 | 377 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2012 | 234 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 619 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2012 | 186 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 2170 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 5071 | 0.020 |
Why?
|
| Female | 2 | 2018 | 142293 | 0.020 |
Why?
|
| Germ Cells | 1 | 2012 | 338 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2012 | 311 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 691 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 2215 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 3317 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1485 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1109 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3818 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 2467 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 6107 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2016 | 11972 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2020 | 5253 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5155 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 12984 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 10067 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 7601 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 6255 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 14561 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8882 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 70367 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 86544 | 0.010 |
Why?
|